Oder Investment Management, LLC Gilead Sciences, Inc. Transaction History

Oder Investment Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $14,287 - $16,202	-195 Reduced 6.41%	2,847 $230,000
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $295 - $322	4 Added 0.13%	3,042 $227,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $4,864 - $5,548	-64 Reduced 2.06%	3,038 $234,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $10,436 - $11,890	135 Added 4.55%	3,102 $257,000
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $184,903 - $265,457	2,967 New	2,967 $254,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $214,833 - $241,967	-3,722 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $17,491 - $21,919	-302 Reduced 7.5%	3,722 $221,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $34,516 - $39,176	532 Added 15.23%	4,024 $292,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $203 - $219	3 Added 0.09%	3,492 $243,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $5,712 - $6,241	-90 Reduced 2.51%	3,489 $240,000
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $252,360 - $287,942	-4,206 Reduced 54.03%	3,579 $231,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $441,020 - $502,521	7,785 New	7,785 $457,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Oder Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Oder Investment Management, LLC with notifications on news.